Pluri (PLUR) Payables (2011 - 2025)

Pluri (PLUR) reported Payables of $1.4 million for Q4 2025, up 29.04% year-over-year from $1.1 million in Q4 2024, and up 63.17% quarter-over-quarter from $877000.0 in Q3 2025.

Pluri (PLUR) Payables (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 15 years of Payables data on file, last reported at $1.4 million in Q4 2025.

  • Payables for Q4 2025 came in at $1.4 million, up 29.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (up 29.04% YoY), and the FY2025 annual result was $1.3 million, up 37.86% from the prior year.
  • Payables grew to $1.4 million in Q4 2025 per PLUR's latest filing, from $877000.0 in the prior quarter.
  • Over five years, Payables peaked at $2.5 million in Q2 2021 and troughed at $877000.0 in Q3 2025.
  • A 5-year average of $1.4 million and a median of $1.3 million in 2022 frame the typical range for Payables.
  • The sharpest annual moves came in 2021 and 2025: Payables sank 49.12% in 2021, then surged 37.86% in 2025.
  • A 5-year view of Payables shows it stood at $1.5 million in 2021, then declined by 24.45% to $1.1 million in 2022, then fell by 10.57% to $981000.0 in 2023, then gained by 13.05% to $1.1 million in 2024, then grew by 29.04% to $1.4 million in 2025.
  • Business Quant data shows PLUR's Payables at $1.4 million in Q4 2025, $877000.0 in Q3 2025, and $1.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 1.05 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 300,549.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 83.00 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 8.69 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 489.30 Mn
9 Abivax 94.37 Bn 94.37 Bn - 34.55 Mn
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 1.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.43 Mn
Sep 30, 2025 877,000.00
Jun 30, 2025 1.33 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 1.11 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 964,000.00
Mar 31, 2024 1.03 Mn
Dec 31, 2023 981,000.00
Sep 30, 2023 973,000.00
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.45 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 1.74 Mn
Mar 31, 2022 2.39 Mn
Dec 31, 2021 1.45 Mn
Sep 30, 2021 2.30 Mn
Jun 30, 2021 2.53 Mn
Mar 31, 2021 2.11 Mn